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During the last 10 years, there have been many major
advances in our understanding of the pathogenesis of glomeru-
tar injury. Of particular significance has been the recognition of
the importance of proteolytic enzymes and oxidants in mediat-
ing glomerular capillary wall and mesangial damage. The infil-
trating polymorphonuclear leukocyte (neutrophil, PMN) and
monocyte have been long recognized as important sources of
proteinases and reactive oxygen species [reviewed in 1—3].
However, it is now known that endogenous glomerular cells
may also release proteinases and oxidants that may also influ-
ence the local inflammatory response [reviewed in 4—8]. In this
brief review, we will highlight some of the studies from our
laboratory that have dealt with these important mediators. For
a more comprehensive discussion of the role of proteinases and
reactive oxygen species in glomerulonephritis (GN), the reader
is referred to several excellent reviews [4—8].
Role of proteinases and oxidants derived from infiltrating cells
In glomerulonephritis (GN)
One of the most critical cells in host defense and inflamma-
tion is the neutrophil (PMN). This "professional phagocyte"
has an important role in the killing of microorganisms via its
ability to release highly toxic reactive oxygen metabolites,
proteinases, and cationic proteins [reviewed in 1—3] (Table I).
Monocytes, and to a much lesser extent, platelets, are also
capable of releasing proteinases and oxidants [1, 9—12]. All of
these cell types may be variably present in the inflamed
glomerulus.
Role of the PMN in glomerular injury
An important role for neutrophils (PMN5) in glomerular
injury has been recognized since the l960s [reviewed in 13].
PMNs can be demonstrated in glomeruli in a variety of prolif-
erative and exudative glomerular diseases in man, including
post-infectious ON, diffuse proliferative lupus nephritis, cryo-
globulinemic GN, Henoch-Schönlein purpura, and various
forms of rapidly progressive glomerulonephritis (RPGN).
PMNs can also be demonstrated within glomeruli in experimen-
tal models of nephritis, especially in models induced with
anti-glomerular basement membrane antibody (nephrotoxic ne-
phritis), or in models associated with subendothelial or mesan-
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gial immune complex deposits [14, 15]. By electron microscopy
the PMNs can often be shown to be activated, and may be
actively phagocytosing immune complexes or be adherent to
denuded glomerular basement membrane (GBM) (Fig. 1). Fur-
thermore, studies in several of these experimental models have
shown that the proteinuria can be reduced or eliminated if the
animal is depleted of PMNs by an anti-PMN antibody [15, 16],
and that proteinuria can be induced in these leukopenic animals
following a PMN transfusion [17]. This provided strong evi-
dence that the PMN can induce glomerular capillary wall injury
with alterations in GBM permeability resulting in proteinuria.
PMN oxidants and glomerular injury
PMNs, when stimulated by immune complexes, activated
complement fragments, and a variety of other stimuli, will
undergo a respiratory burst in which they release several highly
toxic metabolites derived from the step-wise reduction of
oxygen [reviewed in 1]. Principal among the reactive oxygen
products are the superoxide anion (02) and hydrogen peroxide
(H202). PMNs may also generate hydroxyl radical (OH) via the
iron catalyzed interaction of 02 and H202 (Haber-Weiss
reaction), although this reaction appears to be limited in vivo by
the availability of free iron [18, 19]. Recently the formation of
•OH by a myeloperoxidase-dependent mechanism has been
proposed [19]. The formation of singlet oxygen ('02) by intact
PMNs remain controversial [reviewed in 1, see 20 for recent
study in this area].
Some of the most toxic oxygen metabolites produced by
PMNs are those generated by the myeloperoxidase-hydrogen
peroxide (H202)-halide system [1]. Myeloperoxidase (MPO) is a
highly cationic enzyme present in the azurophil (primary)
granules of PMNs which catalyzes the reaction of H202 with a
halide [such as, chloride (Cl)] to generate hypohalous acids
and halogens [1]. These products are capable of killing a variety
of microorganisms as well as mammalian cells [1].
We have examined the ability of the isolated components of
the MPO-H202-halide system to kill cultured rat mesangial cells
as measured by 5'Cr release. Incubation of mesangial cells with
MPO (900 mU/ml) and H202 (l0— M) in Hanks balanced salt
solution (HBSS) as a chloride source resulted in a marked
cytotoxicity (Fig. 2). This was not seen if the mesangial cells
were incubated with MPO alone or H202 alone (Fig. 2). The
cytotoxicity could also be prevented if the MPO was inactivated
(such as by heat or azide), if the H202 was degraded with
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Table 1. Major neutrophil products potentially involved in
glomerular injury
Reactive oxygen metabolites
Superoxide anion (021
Hydrogen peroxide (H202)
Products of the myeloperoxidase-H202-chloride system
Hydroxyl radical (.OH)a
Singlet oxygena
Proteinases
Serine (elastase, cathepsin G, proteinase 3)
Metallo (the 92 kD gelatinase, collagenase)
Cationic proteins
Defensins
Lysozyme
Bactericidallpermeability-increasing factor
Phospholipase products
Leukotnene B4
Thromboxane B2
Platelet activating factor
a Some controversy exists as to whether PMNs produce 0H [18, 191
or singlet oxygen [1].
Fig. 1. Electron micrograph of a PMN adherent to the glomerular
basement membrane in experimental glomerulonephritis. Arrowed is a
PMN within a glomerular capillary of a proteinuric rat with immune
complex nephritis (the concanavalin Alanti-concanavalin A model [15])
48 hours after disease induction. The PMN is adherent to immune
deposits present on the denuded GBM. There is also detachment of the
glomerular epithelial cell from the GBM. (x 12,000).
catalase, or if scavengers of the hypohalous acids were present
(for example, methionine or taurine; Table 2). The cytotoxicity
of the MPO system also requires the presence of a halide (Table
2). Mesangial cells incubated with MPO and/or H202 in HBSS
in which chloride was replaced by sulfate show minimal cyto-
toxicity. With the addition of chloride (10 mM), iodide (0.1 mM),
or bromide (0.1 mM), a significant increase in cell death occurs
(Table 2).
Varani et al have reported that rat MC could be killed by
H202 alone [22]. We were also able to demonstrate that H202
could induce 51Cr release from MC, although it required much
higher concentrations (that is, l0— M or higher) than those
needed for MPO-mediated cytotoxicity (data not shown). In
contrast to our data, however, Varani et a! showed that MPO
inhibited the H202-mediated killing of mesangial cells [221.
However, in their assay system the MPO and H202 were
preincubated for 60 minutes in the presence of bovine serum
albumin prior to the addition of the mesangial cells [221.
Fig. 2. The myeloperoxidase-hydrogen peroxide-halide system is cyto-
toxic to cultured rat mesangial cells. Well characterized rat mesangial
cells [21] that had been labeled overnight with 51Cr (3 jsCilml) were
incubated in various solutions for 1 hour at 37°C and the percent 51Cr
release measured according to standard methods [21]. Significant 51Cr
release was only observed with mesangial cells that were incubated
with active myeloperoxidase (MPO) (900 mU/mi), hydrogen peroxide
(H202) (10 M), and a halide (that is, C1). All experiments were
performed using Hanks balanced salt solution (HBSS) as a source of
chloride (Cl). Incubations were 2 hours. Experiments were performed
in quadruplicate, and data are given as mean SD. The P value
(Student's t-test) for the difference from MPO + H202 and each of the
other three groups (HBSS, MPO alone, and H202 alone) was <0.001.
Peroxidase under these conditions would be expected to utilize
H202 for the production of more powerful oxidants (such as
hypohalous acids) which are scavenged by albumin before they
can react with the target cell. In vivo, the adherence of the PMN
to the target cell may effectively exclude serum proteins and
other scavengers from the site of the MPO reaction [23].
The observation that the MPO system can induce cytotoxic-
ity in vitro suggests that it may play a role in the cellular injury
that accompanies PMN-dependent GN. Given the highly cat-
ionic nature of MPO (isoelectric point> 10), one might hypoth-
esize that release of MPO by the activated PMN within the
glomerulus could result in its localization to the highly anionic
structures within the basement membrane (such as heparan
sulfate proteoglycans) and on the glomerular endothelial or
epithelial cell (such as sialoproteins). In the presence of suffi-
cient local concentrations of H202, the MPO system would then
generate toxic oxidants on the glomerular capillary wall.
To test this hypothesis, we perfused the renal arteries of rats
with MPO (108 sg) followed by H202 (2 ml of l0— M) in
phosphate buffered saline (PBS) [24, 25]. Light and ultrastruc-
tural enzyme histochemistry localized the MPO to the GBM
[24]. Marked glomerular injury was documented, with the
development of modest proteinuria (31 5 mg/24 hr in MPO-
H202 perfused rats vs. 10.0 0.6 mg/24 hr in PBS-perfused
control rats, mean SEM, P < 0.05). Light and electron
microscopy revealed swelling and lysis of the glomerular endo-
thelial and mesangial cells, with fusion of glomerular epithelial
cell foot processes. Large areas of endothelium were denuded
from the GBM, and a pronounced platelet influx was present.
Within several days a marked glomerular cell proliferation
occurred, culminating in a hypercellular lesion resembling
proliferative glomerulonephritis [24, 25]. In contrast, infusion of
MPO alone or H202 alone resulted in no proteinuria and only
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Table 2. The myeloperoxidase-hydrogen peroxide-halide system is
cytotoxic to cultured rat mesangial cells
Reagents % 51Cr release P value
Experiment 1
MPO + 11202 (in HBSS) 75.8 8.3
IMP0 + H202 17.0 1.2 <0.001
MPO + H202 + azide 16.7 1.6 <0.001
MPO + H202 + catalase 15.3 2.4 <0.001
MPO + H202 + methionine 16.4 1.4 <0.001
MPO + H202 + taurine 16.8 3.2 <0.001
Experiment 2
MPO + H202 (chloride-free) 21.4 2.2
MPO + H202 + C1 64.9 3.9 <0.001
MPO + H202 + 1 69.2 2.2 <0.001
MPO + H202 + Br 59.6 2.7 <0.001
Cultured rat mesangial cells [21] were labeled overnight with 51Cr (3
CiJml) and were then incubated in various solutions for 1 hour at 37°C
and the percent 51Cr release measured according to standard methods
[21]. The concentrations of reagents used in these experiments were
MPO (900 mU/mi), 11202 (1O si), azide (100 MM), catalase (250 iJnil),
methionine (5 msi) and taurine (5 mM). MP0 refers to heat-inactivated
MPO. The buffer used in experiment 1 was Hanks balanced Salt
Solution (HBSS) as a source for chloride. In experiment 2 the incuba-
tion was performed in a solution isoosmolar to HBSS but in which the
chloride was replaced by sulfate, The concentrations of the added
halides were Cl' (10mM), 1 (0.1 mM) and Br (0.1 mM). Experiments
were performed in quadruplicate, and data are given as mean SD. The
P value, determined by Student's f-test, is shown for the difference
from MPO + H202 (in HESS) in experiment 1 and from MPO + H202
(chloride-free) in experiment 2.
minor histologic changes (MPO alone, 8.4 0.8 mg/24 hr; H202
alone, 9.2 0.4 mg124 hr) [24, 25].
There is also evidence that the MPO-H202-halide system is
activated in PMN-mediated ON. One of the consequences of
activation of the MPO system is the halogenation of tissue due
to the oxidation of the halide to a form which binds covalently
to tissue proteins [1]. We examined whether there was haloge-
nation (iodination) of GBM in a PMN-mediated model of
immune complex GN in the rat [15]. Rats with GN that received
125l4abeled iodide had significant incorporation of 125! into
glomeruli and GBM. The iodination of GBM as well as protein-
uria were not observed in rats that had been PMN-depleted with
an anti-PMN serum. This provides indirect evidence for the
involvement of MPO in PMN-mediated glomerular disease.
Of great interest has been the recent finding of circulating
anti-MPO antibodies in the majority of patients with idiopathic
crescentic rapidly progressive ON (RPGN) [261. A potential
mechanism by which the anti-MPO antibodies may be patho-
genic has been recently provided by Brouwer et a! [27, 28].
These investigators reported that the infusion of PMN contents
containing MPO, and exogenous H2O2 into the renal artery of
rats that had been pre-immunized with MPO develop a severe
necrotizing crescentic glomerular lesion indistinguishable from
idiopathic RPGN [27, 28]. In this model of RPGN, the disease
process likely results from two mechanisms: (1) the production
of toxic oxygen metabolites on the capillary wall by the
MPO-H202-halide system; and (2) the consequences of the
humoral and cellular immune response to the immune com-
plexes of MPO and anti-MPO on the GBM. Anti-MPO antibod-
ies may also contribute to the lesion by the stimulation of
cytokine-primed PMNs to release oxidants that subsequently
damage endothelial cells [29, 30]. It seems possible that these
mechanisms may be operative in patients who have autoanti-
bodies to MPO and then develop an illness that leads to
intravascular and/or intraglomerular PMN activation.
Other reactive oxygen species may also be involved in
PMN-mediated glomerular injury. For example, the direct renal
artery perfusion in rabbits and/or rats of specific oxidants or of
enzyme systems which have been reported to be capable of
generating O2, H2O2, 'OH, or 102 results in severe glomerular
injury with endothelial cell denudation, mesangiolysis, and
intraglomerular platelet aggregation [31—33]. Studies using scav-
engers of H2O2 [34—37], 02 [37, 38], and OH [39] have also
implicated a role for these oxidants in mediating the proteinuria
in various PMN-dependent models of GN. However, studies
using deferoxamine to inhibit 'OH generation [39] must be
interpreted with caution, as this compound also inhibits MPO-
mediated reactions [40], and can also accelerate the autooxida-
tion of iron with the formation of toxic oxidants [41].
In most of these studies, reactive oxygen species mediate
both cellular injury and an increase in capillary wall permeabil-
ity as reflected by proteinuria. Other studies, however, have
demonstrated that continuous infusion of low concentrations of
H202 for one hour induces proteinuria without evidence for
histologic injury [42]. The mechanism by which oxidants induce
proteinuria in the absence of cellular damage is unknown, but
may relate to direct oxidant injury to the GBM, to hemody-
namic effects, or to the activation of endogenous proteinases.
For example, it is known that oxidants such as those generated
by the MPO system may activate latent type IV collagenases
(gelatinases) capable of degrading GBM [43].
PMN proteinases and glomerular injury
In vitro studies have demonstrated the ability of PMN and
monocyte proteinases to degrade type IV collagen and other
extracellular matrix components present in GBM and mesangial
matrix [44-48]. Proteinases and GBM degradation products can
also be demonstrated in urine in animals and humans with
glomerular diseases in which PMN infiltration is prominent
[49—51].
The principal PMN proteinases involved in GBM degradation
appear to be the PMN serine proteinases, elastase and cathep-
sin G, and a metalloproteinase, the 92 lcD type IV collagenase/
gelatinase [45—48]. We have studied the in vivo consequences of
infusing purified PMN elastase into the renal artery of rats [52].
Infusion of small quantities of active enzyme (that is, 50 sg)
induced massive but transient proteinuria (Fig. 3). No signifi-
cant proteinuria developed if rats were infused with inactivated
elastase, despite the fact that both active and inactive elastase
localized to the glomerular capillary wall as shown by immu-
nofluorescence. Cathepsin 0, but not inactivated cathepsin G,
also induced severe proteinuria (Fig. 3). It was of interest that
the proteinuria induced by these proteinases was not associated
with any evidence of histologic damage by light or electron
microscopy. Our interpretation is that these proteinases act
primarily to degrade extracellular matrix components within the
GBM as opposed to being directly toxic to the various glomer-
ular cell populations. This is also supported by studies of
nephrotoxic nephritis in mice that have PMNs that are deficient
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Fig. 3. Effect of renal artery perfusion of
various PMN components on inducing
proteinuria in rats. Shown is the 24-hour urine
protein excretion induced in rats by the renal
artery perfusion of phosphate buffered saline
(PBS) (N = 15), or by the following PMN
products in PBS: elastase (N = 13),
inactivated elastase (In-elastase) (N = 6),
cathepsin G (N = 4), inactivated cathepsin G
(In-cathepsin G) (N = 4), proteinase 3 (N = 4
at 50 sg, N = 1 at 385 pg), or a mixture of
human defensins 1, 2, and 3 (N = 6). The
doses administered are shown under each bar.
All perfusions were administered to rats that
had previously undergone a unilateral
nephrectomy. Values shown are mean SEM.
in neutral proteinases [53]. These mice have significant evi-
dence of glomerular endothelial cell injury (presumably an
oxidant-mediated effect) but little proteinuria [53].
Recently a third neutral serine proteinase has been identified
in PMNs and has been named proteinase 3 [2, 54]. By ultra-
structural immunocytochemistry, proteinase 3 has been shown
to reside in the MPO-positive primary granules and on the
plasma membrane of the PMN [55]. Proteinase 3 can degrade
several extracellular matrix components, including type IV
collagen and laminin [56], and can induce emphysema in
hamsters upon intratracheal injection [54]. Much attention has
been focussed on proteinase 3 following the recent identifica-
tion of this proteinase as the antigen to which the anti-neutro-
phil cytoplasmic antibody is directed against in Wegener's
granulomatosis [57].
We have examined the ability of proteinase 3 to induce
glomerular injury in vivo (Johnson R, Gray B, and Klebanoff SJ,
unpublished data). Rats underwent a unilateral nephrectomy
followed by renal artery perfusion of the remaining kidney as
previously described [52]. PBS (0.5 ml) is first injected to
displace the blood from the kidney, followed by infusion of the
proteinase. Unlike elastase and cathepsin G, infusion of 50 p.g
of purified proteinase 3 did not induce proteinuria (12 2 mg/24
hr, normal range 15 3 mg/24 hr; Fig. 3). However, doses of
100 g, 150 and 385 jsg given to individual rats resulted in
24, 21, and 248 mg proteinuria, respectively. As with the
elastase-perfused rats, light microscopy revealed no abnormal-
ities. This would again be consistent with the hypothesis that
the proteinuria induced with high dose proteinase 3 is the
consequence of degradation of the GBM as opposed to glomer-
ular cell injury.
PMN cationic proteins and glomerular injury
In addition to proteinases and oxidants, PMNs can also
release cationic proteins with bactericidal activity, including
lysozyme, bactericidal/permeability increasing factor, and the
small 3.3 to 3.9 kD defensins [reviewed in 2]. A variety of
studies have suggested that intraglomerular release of cationic
proteins from neutrophils and platelets may result in their
Fig. 4. Localization of human defensins to the glomerular capillary
and mesangium following renal artery perfusion in the rat. Shown is a
glomerulus of a rat that has been perfused with defensin (100 sg 5 mm
previously) and then immunostained with a rabbit anti-defensin anti-
body. Defensin is localized to the mesangium and capillary wall.
Vehicle-perfused rats were negative when immunostained with the
anti-defensin antibody. (Indirect immunofluorescence, x400).
localization to the glomerular capillary wall [58, 59], where they
may have a role in increasing capillary wall permeability by
neutralizing the anionic components of the GBM [reviewed in
60]. We therefore examined whether the renal artery perfusion
of defensins could induce proteinuria in rats (Fig. 3). Infusion of
100 pg of purified human defensins (containing a mixture of
defensins 1, 2, and 3 (1:1:0.5) resulted in minimal proteinuria (21
2 mg124 hr, N = 6) and normal histology. Similarly, larger
doses (that is, 500 sg) given to two rats also resulted in only
13.1 and 24.0 mg proteinuria in the first 24 hours. The defensins
could be shown to bind to the glomerular mesangium and
capillary wall by immunofluorescence with a specific antibody
(Fig. 4), and in separate experiments, the binding of '25I-labeled
defensins to glomeruli by a double isotope binding assay [61]
was documented to be 29.1 1% immediately after perfusion.
Thus, it would appear that defensins, while binding to the
glomerular capillary wall, may not contribute significantly to
PMN-mediated glomerular injury.
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Role of platelets in PMN-mediated glomerular injury
An interesting observation is the frequent co-localization of
platelets with PMNs within glomeruli in immune complex
nephritis [62, 631. This is particularly evident in a PMN-
dependent model of immune complex GN in the rat resembling
diffuse proliferative lupus nephritis (the concanavalin A-anti-
concanavalin A model) in which subendothelial and mesangial
deposits are prominent [63]. To investigate the role of platelets
in this model, we studied rats with GN that had been previously
depleted of platelets with an anti-platelet antibody [61]. Platelet
depletion significantly reduced proteinuria without affecting
PMN localization. Since PMN depletion also decreases the
proteinuria in this model [15], this suggests that both platelets
and PMNs are important mediators of the capillary wall injury.
While it is possible that platelets could injure the capillary
wall independently of PMNs via the release of vasoactive
amines, proteases, oxidants, thromboxane, and other platelet
products [reviewed in 64], indirect evidence suggests a potential
PMN-platelet interaction. Numerous in vitro studies have dem-
onstrated that platelets can affect various PMN functions [re-
viewed in 64, 65]. Some of these functions may be mediated by
GMP-140, a recently recognized platelet granule membrane
glycoprotein that redistributes to the plasma membrane when
platelets are activated, and mediates the adherence of the
activated platelets to PMNs [66]. Of particular relevance has
been the observation that platelets are also required for the
PMN-mediated lung injury that occurs in rats after systemic
complement activation [67]. It has been proposed that this is
mediated by platelet adenine nucleotides (ATP and ADP),
which act to enhance 02 and MPO release by the PMN [67,
68]. The recent observation that rats with mesangial prolifera-
tive GN have an increased glomerular 02 response when
administered the ATP analog, ATPyS, [69] would be consistent
with this hypothesis.
Role of proteinases and oxidants derived from intrinsic
glomerular cells in GN
Mesangial cell proteinases and oxidants in glomerular injury
The observation that glomerular cells can generate reactive
oxygen species was first demonstrated by Shah in 1981 [70]. It
is now known that mesangial cells produce oxidants in response
to multiple stimuli, including immune complexes, the comple-
ment membrane attack complex, and various cytokines [71—74].
The precise role of mesangial cell-derived oxidants in the
evolution of glomerular injury remains to be defined. As expo-
sure of basement membrane or extracellular matrix components
to reactive oxygen species facilitates degradation by protein-
ases [75], it may be that local release of these compounds during
glomerular inflammation augments proteinase-mediated struc-
tural damage.
Early studies utilizing mesangial cells described a non-spe-
cific neutral protease activity within culture supernatants [76,
77]. This activity displayed notable features, including depen-
dence on zinc for activity, secretion in a latent, proenzyme
form, and activity against isolated glomerular basement mem-
branes [76]. Subsequent purification and characterization of the
proteolytic activities secreted by cultured human and rat me-
sangial cells have defined the structural and molecular features
of these enzymes [78—81]. Two major matrix metalloproteinases
have been identified in this manner: matrilysin (PUMP-i) and
the 72 kD Type IV collagenase [78—81]. Matrilysin was identi-
fied in cultured human mesangial cells by a PCR-based homol-
ogy cloning strategy [81]. In addition, matrilysin activity was
purified and identified on the basis of specific substrate activi-
ties and by the use of specific anti-peptide antibodies. The
abundance of the matrilysin mRNA was specifically induced by
the inflammatory cytokines, interleukin 1 and tumor necrosis
factor. The matrilysin protein was also detected within the
mesangial region of clinical biopsy specimens of acute prolifer-
ative glomerulonephritis, particularly in those cases character-
ized by infiltrating monocytes expressing interleukin 1 [81].
The 72 kD Type IV collagenase activity produced by mesan-
gial cells has been rigorously characterized by extensive puri-
fication and amino acid sequence analysis [78, 79]. The expres-
sion of this enzyme in most studied cells appears to be
constitutive, with little response to inflammatory cytokines or
phorbol esters [82]. In contrast, studies with cultured human or
rat mesangial cells have demonstrated both cytokine-mediated
and second-messenger inducibility [83]. Mesangial cell synthe-
sis of the 72 kD Type IV collagenase is induced by interleukin
1, tumor necrosis factor, and transforming growth factor /31
(TGF-f31) [83]. In addition, elevation of cyclic AMP induces
mesangial cell synthesis of the enzyme [83]. Recent studies
have defined the presence of multiple AP-2 sites, several
oncogene binding motifs, and a probable TGF-f31 activation
element (Lovett et al, manuscript submitted for publication).
Thus, the regulation of this gene in vivo may be subjected to
multiple levels of tissue-specific control by inflammatory cyto-
kines.
Recently we have investigated the expression of the 72 kD
Type IV collagenase in a rat model of mesangial proliferative
GN induced by injecting an antibody directed against the Thy 1
antigen expressed on the surface of mesangial cells [80]. The
model results in an acute complement mediated injury to the
mesangium, with dissolution of the mesangial matrix and loss of
mesangial cells ("mesangiolysis"), followed by a marked pro-
liferative response with matrix expansion [84]. In normal gb-
meruli, approximately 10% of the mesangial cell population
express the 72 kD Type IV collagenase, usually in areas
immediately adjacent to the basement membrane. Following
induction of Thy 1 nephritis there is a dramatic increase in the
abundance of 72 kD Type IV collagenase-expressing cells,
especially within foci of proliferating cells and in regions of
mesangial matrix dissolution. The Type IV collagenase antigen
was also localized to sites of obvious GBM disruption, suggest-
ing that augmented secretion of this enzyme may account for
the proteinuria that is variably observed in this model.
Other proteinases may also be involved in mesangial prolif-
erative diseases. Recently Tomooka et al have shown that
plastninogen activator activity is reduced and plasminogen
activator inhibitor-i synthesis is increased in diseased glomeruli
from rats with Thy 1 nephritis [85]. The authors suggested that
this may be one of the mechanisms by which matrix accumu-
lates in this disease model.
Glomerular epithelial cell proteinases and oxidants and
glomerular injury
Several studies, primarily in vivo, have suggested that oxi-
dants mediate glomerular injury in PMN-independent models of
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glomerular disease associated with injury to the glomerular
epithelial cell [86—90]. Thus, studies in rats with aminonucleo-
side nephrosis [871, passive Heymann nephritis [88, 89], and a
complement-independent model of membranous GN [901 have
all reported a reduction in proteinuna with the administration of
0H scavengers. Scavengers of 02, or inhibitors of 02
formation, also reduce proteinuria in the aminonucleoside
model [86, and reviewed in 6].
Glomerular epithelial cells also produce several proteinases,
including cathepsin D [91], urokinase-type plasminogen activa-
tor [92], and several variably characterized neutral metallopro-
teinases [93, 94]. While several investigators have suggested
that cultured glomerular epithelial cells secrete the 92 and 72 kD
Type V collagenases (M. Davies, personal communication), our
laboratories have focused on the purification and characteriza-
tion of a distinct set of Type IV collagen-degrading activities.
Gelatin zymographic analysis demonstrates three proteolytic
activites with molecular masses of 220, 150, and 98 kD. These
masses distinguish these proteases from the known members of
the collagenase supergene (matrix metalloproteinase) family.
All of these activities are dependent upon zinc for activity.
Significantly, these activities are not secreted in latent, pro-
enzyme form and are not inhibited by recombinant tissue
inhibitor of metalloprotease-2. Ultimate identification of these
enzymes awaits the structural and molecular characterization
currently underway in our laboratories, which is utilizing a
combined protein purification and expression cloning strategy.
A possible role for these enzymes in glomerular disease is
supported by the observation of a nine-fold increase in gelati-
nase activity in glomerular homogenates from rats with active
Heymann's nephritis [94]. Neutral proteinases have also been
isolated from the urine of rats with aminonucleoside nephrosis
in which the principal lesion is of the glomerular epithelial cell
[51].
Finally, there is evidence for other GBM-degrading protein-
ases in glomeruli, although the specific cellular source within
the glomerulus remains unknown. These include a 116 to 120
kD membrane associated metalloproteinase [95] as well as the
cysteine proteinases, cathepsins B, H, and L [96, 97]. The 116
kD membrane-associated enzyme is active against basement
membrane substrates, and recent studies have detected a sim-
ilar activity within plasma membrane preparations of cultured
glomerular epithelial cells (D. Lovett, unpublished data). The
biological significance of these various activites is not well
defined, although administration of cysteine proteinase inhibi-
tors to rats with a PMN-independent, complement-independent
model of nephrotoxic nephritis reduces proteinuria by 40 to
45% [98].
Conclusion
Proteinases and oxidants are likely to have an important role
in both PMN-dependent and PMN-independent GN. In PMN-
mediated injury, the release of reactive oxygen species (and
especially products of the MPO-H202-halide system) by the
PMN may result in direct injury of the intrinsic cells within the
glomerulus as well as halogenation and oxidation of the GBM
that results in an increase in permeability. In contrast, PMN
serine proteinases do not appear to cause cellular toxicity but
rather cause degradation of GBM components that results in
substantial proteinuria. PMN defensins, despite localizing to
the GBM and mesangial matrix, induce little or no proteinuria
or morphologic evidence of cellular injury.
Oxidants and proteinases derived from resident glomerular
cells may also cause or amplify glomerular injury. Mesangial
cells can release oxidants and proteinases in response to a
variety of inflammatory mediators, and the up-regulated expres-
sion of type IV collagenase in mesangial proliferative nephritis
may have an important role in the remodeling and restoration of
the normal mesangial matrix. Finally, evidence suggests that
glomerular epithelial cells make oxidants and GBM-degrading
proteinases, and that these may be involved in proteinuric
diseases characterized by injury to the glomerular epithelial
cell.
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